Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether intravenous tramadol, with magnesium sulfate, can prevent shivering. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)
  • Tramadol (tramadol)

Snippet

Sponsor: Al-Azhar University | Conditions: Lower Extremity Chronic Venous Ulcers, Varicose Veins Leg | Phase 4 | Status: NOT_YET_RECRUITING